Dr. Yessar M. Hussain

Neurology
4705 Spicewood Springs Rd, 
Austin, TX 
Accepting New Patients
Offers Telehealth
20 Years of Experience
4705 Spicewood Springs Rd, 
Austin, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yessar Hussain is a Neurologist in Austin, Texas. Dr. Hussain has been practicing medicine for over 20 years and is rated as an Experienced provider by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Cervical Myelopathy, Invertebral Disc Disease, Fractured Spine, and Sciatica. Dr. Hussain is currently accepting new patients.

His clinical research consists of co-authoring 13 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Baghdad, 2006
Residency
SUNY Upstate University Hospital
Specialties
Neurology
Licenses
Electrodiagnostic Medicine in TX
Board Certifications
American Board Of Psychiatry And Neurology
Fellowships
Barnes Jewish Hospital/Washington University
Hospital Affiliations
Saint Joseph Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Yessar Hussain MD PA
4705 Spicewood Springs Rd, Austin, TX 78759
Other Locations
Yessar Hussain MD PA
3301 River Rd, Austin, TX 78703

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 6-Month Extension Study Following Protocol VMALS-002-2 (A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis)
A 6-Month Extension Study Following Protocol VMALS-002-2 (A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis)
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other, Biological
Study Drug: Engensis
Study Phase: Phase 2
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
A Phase 2a, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Other, Biological
Study Drug: Engensis
Study Phase: Phase 2
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, Safety, and Tolerability of PXT3003 in Charcot-Marie-Tooth Type 1A (CMT1A)
Enrollment Status: Active_not_recruiting
Publish Date: April 03, 2024
Intervention Type: Drug
Study Drug: (RS)-Baclofen, Naltrexone Hydrochloride and D-Sorbitol
Study Phase: Phase 3
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
A Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) and Immune Globulin Infusion (Human), 10% (GAMMAGARD LIQUID/KIOVIG) for the Treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Enrollment Status: Completed
Publish Date: May 24, 2023
Intervention Type: Biological
Study Drugs: HYQVIA, Intravenous Immunoglobulin G
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
Enrollment Status: Completed
Publish Date: August 16, 2022
Intervention Type: Drug
Study Drug: Lenabasum
Study Phase: Phase 3
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations (PAIN-CONTRoLS)
Enrollment Status: Completed
Publish Date: July 06, 2018
Intervention Type: Drug
Study Phase: Phase 4
View 5 Less Clinical Trials

13 Total Publications

Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.
Impact of patisiran on polyneuropathy of hereditary transthyretin amyloidosis in patients with a V122I or T60A variant: a phase IV multicenter study.
Journal: Annals of medicine
Published: September 20, 2025
Similar Doctors
Distinguished in Peripheral Neuropathy
Dr. Justin X. Mussomeli
Neurology
Distinguished in Peripheral Neuropathy
Dr. Justin X. Mussomeli
Neurology

Scott And White Clinic

302 University Blvd, 
Round Rock, TX 
 (13.8 miles away)
512-509-0200
Languages Spoken:
English
See accepted insurances

Justin Mussomeli is a Neurologist in Round Rock, Texas. Dr. Mussomeli is rated as a Distinguished provider by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Peripheral Neuropathy, Foot Drop, Memory Loss, and Migraine.

Distinguished in Peripheral Neuropathy
Dr. Bill D. Davis
Neurology
Distinguished in Peripheral Neuropathy
Dr. Bill D. Davis
Neurology

Advent Health - San Marcos

1305 Wonder World Drive, Suite 307, 
San Marcos, TX 
 (37.8 miles away)
512-353-8658
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bill Davis is a Neurologist in San Marcos, Texas. Dr. Davis is rated as a Distinguished provider by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Cerebellar Degeneration, Peripheral Neuropathy, Migraine, and Progressive Myoclonic Epilepsy. Dr. Davis is currently accepting new patients.

Advanced in Peripheral Neuropathy
Dr. Scott A. Boruchow
Neurology
Advanced in Peripheral Neuropathy
Dr. Scott A. Boruchow
Neurology

Austin Regional Clinic PA

2785 E 7th St, Austin Regional Clinic Eas, 
Austin, TX 
 (8.6 miles away)
737-910-6700
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Scott Boruchow is a Neurologist in Austin, Texas. Dr. Boruchow is rated as a Distinguished provider by MediFind in the treatment of Peripheral Neuropathy. His top areas of expertise are Cerebellar Degeneration, Migraine, Peripheral Neuropathy, and Migraine with Brainstem Aura. Dr. Boruchow is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hussain's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile